|
Volumn 93, Issue 10, 2014, Pages 1705-1715
|
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PREDNISONE;
RITUXIMAB;
VINCRISTINE;
ADULT;
AGED;
ANXIETY;
CHEMICALLY INDUCED;
ECONOMICS;
ETIOLOGY;
FATIGUE;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL DISEASES;
HUMAN;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MALE;
MIDDLE AGED;
NETHERLANDS;
NEURALGIA;
PARESTHESIA;
PATIENT SATISFACTION;
PSYCHOLOGY;
QUALITY OF LIFE;
QUESTIONNAIRE;
REGISTER;
SURVIVOR;
SYMPTOM ASSESSMENT;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANXIETY;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FATIGUE;
FEMALE;
FOLLOW-UP STUDIES;
GASTROINTESTINAL DISEASES;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MALE;
MIDDLE AGED;
NETHERLANDS;
NEURALGIA;
PARESTHESIA;
PATIENT SATISFACTION;
PREDNISONE;
QUALITY OF LIFE;
QUESTIONNAIRES;
REGISTRIES;
SURVIVORS;
SYMPTOM ASSESSMENT;
VINCRISTINE;
|
EID: 85027945463
PISSN: None
EISSN: 14320584
Source Type: Journal
DOI: 10.1007/s00277-014-2099-8 Document Type: Article |
Times cited : (38)
|
References (0)
|